Company intelligence / Profile preview

ITP Invest

Stockholm, Sweden

Ownership: Private
Development stage: Other

Overview

ITP Invest is a Swedish investment firm that specializes in the life sciences and biotechnology sectors within the Nordic region. The company focuses on small to medium-sized enterprises with significant growth potential, distinctive technology, and ready-to-market products or services. ITP Invest typically targets businesses that have already secured at least one paying customer and are led by experienced management teams. Its portfolio includes notable Swedish biotech and healthcare companies such as BioArctic, Immunicum, and Swedish Orphan Biovitrum (Sobi).

Industry: Investors

Partnerships

HandelsbankenAbris Capital Partners

Beyond the preview

Go deeper on ITP Invest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ITP Invest.

Explore the full profile